Hyderabad: The Government of India has banned the manufacture, sale, and distribution of immediate-release oral Nimesulide formulations exceeding 100 mg for human use. The Centre bans high-dose Nimesulide due to serious health risks associated with these oral drugs. Additionally, the availability of safer alternatives has influenced this decision. It reinforces the Centre’s resolution to ban high-dose Nimesulide to ensure public well-being.
The ban came into immediate effect following a Gazette Notification issued on December 29, 2025. In response, the Drugs Control Administration (DCA), Telangana, has alerted citizens across the state about the Centre’s decision on high-dose Nimesulide.
Telangana DCA urges public to avoid banned Nimesulide formulations
Officials have urged the public to stop using these high-dose Nimesulide medicines. They recommend consulting registered medical practitioners for alternative treatments. Citizens have also been warned not to purchase, store, or consume the banned drugs under any circumstances. They must adhere to the broader directive as the Centre bans high-dose Nimesulide.
To enforce the ban, authorities are actively removing the prohibited products from the market and the pharmaceutical supply chain in Telangana. The DCA has asked the public to report any violations to the nearest Drugs Inspector or local DCA office.
The move is aimed at safeguarding public health and promoting responsible drug usage across the state.